Clinical Trial Update: Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cetuximab in combination with capecitabine, oxaliplatin and bevacizumab for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Dutch Colorectal Cancer Group | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED